Elizabeth H.Z. Thompson
EVP, Head of Research & Dev · ACADIA PHARMACEUTICALS INC
- 2024
- Jul 31, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Elizabeth H.Z. Thompson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elizabeth H.Z. Thompson?
Elizabeth H.Z. Thompson is a corporate insider, tracked as EVP, Head of Research & Dev of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Elizabeth H.Z. Thompson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Elizabeth H.Z. Thompson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($506K) across all tracked filings.
